改变的处理与慢性β-上腺体刺激的心脏毒性影响有关重要
Stefan Engelhardt1, Lutz Hein, Vitaly Dyachenkow
1Institute of Pharmacology and Toxicology, of Wuerzburg, Germany. stefan.engelhardt@virchow.uni-wuerzburg.de
在具有β1-上腺素受体过度表达的小鼠中消化索兰班可挽救心力衰竭. 这种遗传修饰使心脏功能,结构和基因表达正常化,突出显示了处理的过程.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 基因工程是一种基因工程.
背景情况:
- 慢性β-上腺刺激有助于心脏缩和心脏衰竭.
- 介导β-上腺素刺激有害影响的途径尚未完全理解.
- 在心力衰竭模型中研究处理的基因改造.
研究的目的:
- 为了确定删除索兰班是否会影响贝塔1-上腺素受体转基因小鼠心力衰竭的发展.
- 为了研究处理在β-上腺素受体诱导的心力衰竭中的作用.
主要方法:
- 交叉β1-上腺素受体转基因 (β1TG) 的小鼠与斯福兰班缺乏 (PLB-/-) 的小鼠.
- 评估生存率,心脏功能 (左心室收缩性),心脏缩,纤维化和基因表达.
- 分析了细胞内过渡性和透缩性水平.
主要成果:
- 在β1TG小鼠中,索兰班除显著改善了生存率.
- 在β1TG/PLB-/-小鼠中,心脏功能,缩和纤维化正常化.
- 在β1TG小鼠中,异常的细胞内处理被斯福兰班切除所纠正.
结论:
- 通过废除索兰班来修改的处理,可以在beta1-adrenergic受体转基因小鼠中挽救心力衰竭特征.
- 改变的处理对于心脏中的β1-上腺体信号的有害影响至关重要.
- 索兰班缺乏症可以防止β1-上腺素受体诱导的心脏功能障碍.
更多相关视频
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
相关概念视频
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Skeleton and Calcium Homeostasis
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
